 Carl Icahn |
Sard Verbinnen & Co. represents SandRidge Energy as it adopts a “poison pill” provision to head off a potential raid by activist Carl Icahn, who has knocked its $750M proposal to acquire Bonanza Energy.
Owner of a 13.5 percent stake in SandRidge, Icahn has blasted the Bonanza deal as “nonsensical.” In last week's federal filing, he questioned management's "possible justifications" for the deal.
The poison pill precludes any investor from acquiring more than a 10 percent stake in the Oklahoma-based company and "grandfathers in" current investors.
SandRidge chairman John Genova called the poison pill, which expires a year from now, a short-term move to protect shareholder rights to vote on the merger plan with Bonanza.
The rights plan is “designed to deter the acquisition of actual, de facto or negative control of the company by any person or group without appropriately compensating its shareholders for such control,” according to SandRidge’s Nov. 27 statement.
SV&C’s Bryan Locke and Kelly Kimberly handle media for SandRidge.
Interpublic posted a 5.1 percent drop in Q3 net revenues to $2.5B as CEO Philippe Krakowsky reports the final financial results of the publicly traded company.
Joele Frank handles Pine Gate Renewables as the Asheville, NC-based solar power development company declares Chapter 11 in the aftermath of Donald Trump’s cuts to wind & solar tax credits.
Stagwell CEO Mark Penn reports Q3 net revenues jumped 6 percent to $614.5M, a record performance for a non-political period. Operating income soared 45.7 percent to $60.9M.
Joele Frank works for Klöckner Pentaplast as the German maker of plastic films declares Chapter 11. A successful reorganization would slash its its corporate debt by $1.5B.
Teneo represents Metsera, the New York City biotech focused on weight-control products, which is subject to a bidding war between heavyweights Novo Nordisk and Pfizer.
